Edgar Engleman is Director & 10% Owner at Bolt Biotherapeutics, Inc. (BOLT). They have made 7 open-market trades across 3 companies since 2017, most recently 2023-11-30.
CIK 0001227162
3 open-market purchases totalling $10.7M since 2017, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BOLT | SELL | 2023-11-29 | 2023-12-01 | $0.87 | $222K | +13.1% | +29.9% | +27.7% |
| BOLT | SELL | 2023-11-21 | 2023-11-22 | $0.90 | $2K | -0.3% | +7.0% | +23.3% |
| BOLT | SELL | 2023-11-16 | 2023-11-20 | $0.93 | $46K | -5.3% | +7.4% | +22.3% |
| BOLT | BUY | 2021-02-09 | 2021-02-09 | $20.00 | $4.0M | -3.8% | +10.2% | -35.5% |
| BOLT | SELL | 2021-02-09 | 2021-02-09 | $20.00 | $3K | -3.8% | +10.2% | -35.5% |
| SLNO | BUY | 2017-12-15 | 2017-12-19 | $1.84 | $4.0M | +11.6% | +20.1% | +12.8% |
| CAPN | BUY | 2017-03-07 | 2017-04-14 | $0.96 | $2.7M | -7.3% | +11.1% | +11.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.